Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ergoloid mesylate alpha adrenergic receptor small molecule NA drugbank , DGIDB Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate alpha adrenergic receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate alpha adrenergic receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate alpha adrenergic receptor small molecule NA drugbank , DGIDB Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate alpha adrenergic receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate alpha adrenergic receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate beta adrenergic receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate beta adrenergic receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate beta adrenergic receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate dopamine receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate dopamine receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate dopamine receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate dopamine receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate dopamine receptor small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
ergoloid mesylate serotonin receptors small molecule NA drugbank Prescription of drug (procedure)[MeSHID:D011307]
Disease[MeSHID:D004194]
Cognition Disorders[MeSHID:D003072]
Neoplasm Metastasis[MeSHID:D009362]
Delirium[MeSHID:D003693]
Respiratory Diaphragm[MeSHID:D003964]
Mood (psychological function)[MeSHID:D000339]
Mental Suffering[MeSHID:D013315]
Conditioning (Psychology)[MeSHID:D003213]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved antagonist,agonist
click here to return to the previous page